References
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
- Vaca L. Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease. Sensors. 2014;14(5):9117–9131.
- De Planell-Saguer M, Rodicio MC. Detection methods for microRNAs in clinic practice. Clin Biochem. 2013;46(10–11):869–878.
- Madhavan D, Cuk K, Burwinkel B, et al. Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Front Genet. 2013;4:116.
- Asaga S, Kuo C, Nguyen T, et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem. 2011;57(1):84–91.
- He Y, Lin J, Kong D, et al. Current state of circulating microRNAs as cancer biomarkers. Clin Chem. 2015;61(9):1138–1155.
- Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105(30):10513–10518.
- Nadal E, Truini A, Nakata A, et al. A novel serum 4-microRNA signature for lung cancer detection. Sci Rep. 2015;5:12464.
- Zheng D, Haddadin S, Wang Y, et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol. 2011;4(6):575.
- Neilsen CT, Goodall GJ, Bracken CP. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012;28(11):544–549.
- Guo L, Chen F. A challenge for miRNA: multiple isomiRs in miRNAomics. Gene. 2014;544(1):1–7.
- Telonis AG, Loher P, Jing Y, et al. Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucl Acids Res. 2015;43(19):9158-9175.
- Loher P, Londin ER, Rigoutsos I. IsomiR expression profiles in human lymphoblastoid cell lines exhibit population and gender dependencies. Oncotarget. 2014;5(18):8790–8802.
- Siddle KJ, Tailleux L, Deschamps M, et al. Bacterial infection drives the expression dynamics of microRNAs and their isomiRs. PLoS Genet. 2015;11(3):e1005064–e1005064.
- Farina NH, Wood ME, Perrapato SD, et al. Standardizing analysis of circulating microRNA: clinical and biological relevance. J Cell Biochem. 2014;115(5):805–811.
- Moldovan L, Batte KE, Trgovcich J, et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18(3):371–390.
- Kirchner B, Paul V, Riedmaier I, et al. mRNA and microRNA purity and integrity: the key to success in expression profiling. Methods Mol Biol. 2014;1160:43–53.
- McAlexander MA, Phillips MJ, Witwer KW. Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid. Front Genet. 2013;4:83.
- Redshaw N, Wilkes T, Whale A, et al. A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability. Biotechniques. 2013;54(3):155–164.
- Eikmans M, Rekers NV, Anholts JDH, et al. Blood cell mRNAs and microRNAs: optimized protocols for extraction and preservation. Blood. 2013;121(11):e81–9.
- Page K, Guttery DS, Zahra N, et al. Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One. 2013;8(10):e77963.
- Roberts TC, Coenen-Stass AML, Betts CA, et al. Detection and quantification of extracellular microRNAs in murine biofluids. Biol Proced Online. 2014;16(1):5.
- Kim Y-K, Yeo J, Kim B, et al. Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell. 2012;46(6):893–895.
- Qing’En L, Guoqiang W, Khei HY, et al. Multiplexed, direct miRNA quantification from cell lysates without RNA isolation. Protoc Exchange. 2011. doi:10.1038/protex.2011.202
- Medina RJ, O’Neill CL, Sweeney M, et al. Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genom. 2010;3:18.
- Kumar P, Johnston BH, Kazakov SA. miR-ID: A novel, circularization-based platform for detection of microRNAs. RNA. 2011;17(2):365–380.
- Krysan K, Kusko R, Grogan T, et al. PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC. Mol Cancer Res. 2014;12(5):765–774.
- Tang F, Hajkova P, Barton SC, et al. MicroRNA expression profiling of single whole embryonic stem cells. Nucl Acids Res. 2006;34(2):e9.
- Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucl Acids Res. 2005;33(20):e179.
- Soundara Pandi SP, Chen M, Guduric-Fuchs J, et al. Extremely complex populations of small RNAs in the mouse retina and RPE/choroid. Invest Ophthalmol Vis Sci. 2013;54(13):8140–8151.
- Schamberger A, Orbán TI. 3’ IsomiR species and DNA contamination influence reliable quantification of microRNAs by stem-loop quantitative PCR. PLoS One. 2014;9(8):e106315.
- Honda S, Kirino Y. Dumbbell-PCR: a method to quantify specific small RNA variants with a single nucleotide resolution at terminal sequences. Nucl Acids Res. 2015;43(12):e77.
- Ho YK, Xu WT, Too HP. Direct quantification of mRNA and miRNA from cell lysates using reverse transcription real time PCR: A multidimensional analysis of the performance of reagents and workflows. PLoS One. 2013;8:e72463.
- Wan G, Lim Q, Too H-P. High-performance quantification of mature microRNAs by real-time RT-PCR using deoxyuridine-incorporated oligonucleotides and hemi-nested primers. RNA. 2010;16(7):1436–1445.
- Benes V, Collier P, Kordes C, et al. Identification of cytokine-induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay. Sci Rep. 2015;5:11590.
- Basu C. PCR primer design. New York: Springer; 2015.
- Untergasser A, Cutcutache I, Koressaar T, et al. Primer3—new capabilities and interfaces. Nucl Acids Res. 2012;40(15):e115–e115.
- Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics. 2007;23(10):1289–1291.
- Vallone PM, Butler JM. AutoDimer: a screening tool for primer-dimer and hairpin structures. Biotechniques. 2004;37(2):226–231.
- Busk PK. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinform. 2014;15:29.
- Jacobsen N, Andreasen D, Mouritzen P. Profiling microRNAs by real-time PCR. In Dalmay T, editor. MicroRNAs in development: methods and protocols, methods in molecular biology, vol. 732, New York: Springer. 2011, p. 39-54.
- Arora A, McKay GJ, Simpson DAC. Prediction and verification of miRNA expression in human and rat retinas. Invest Ophthalmol Vis Sci. 2007;48(9):3962–3967.
- Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11(8):809–815.
- Satterfield BC. Cooperative primers: 2.5 million-fold improvement in the reduction of nonspecific amplification. J Mol Diagn. 2014;16(2):163–173.
- Poritz MA, Ririe KM. Getting things backwards to prevent primer dimers. J Mol Diagn. 2014;16(2):159–162.
- Ruijter J, Ramakers C, Hoogaars W, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucl Acids Res. 2009;37(6):e45–e45.
- Ramakers C, Ruijter JM, Deprez RHL, et al. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett. 2003;339(1):62–66.
- Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. Rna. 2008;14(5):844–852.
- Davoren PA, McNeill RE, Lowery AJ, et al. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 2008;9(1):76.
- Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–622.
- Bustin SA, Beaulieu J-F, Huggett J, et al. MIQE precis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol. 2010;11(1):74.
- Farrar JS, Wittwer CT. Extreme PCR: efficient and specific DNA amplification in 15–60 seconds. Clin Chem. 2015;61(1):145–153.
- Weiland M, Gao X-H, Zhou L, et al. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol. 2012;9(6):850–859.
- Andrews WJ, Brown ED, Dellett M, et al. Rapid quantification of microRNAs in plasma using a fast real-time PCR system. Biotechniques. 2015;58(5):244.
- Agrawal S, Cifelli S, Johnstone R, et al. Utilizing low-volume aqueous acoustic transfer with the echo 525 to enable miniaturization of qRT-PCR assay. J Lab Autom. 2016;21(1):57-63.
- Huggett JF, O’Grady J, Bustin S. qPCR, dPCR, NGS-A journey. Biomol Detect Quant. 2015;3:A1–A5.
- Ma J, Li N, Guarnera M, et al. Quantification of plasma miRNAs by digital PCR for cancer diagnosis. Biomark Insights. 2013;8:127.
- Hindson CM, Chevillet JR, Briggs HA, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10(10):1003–1005.
- Conte D, Verri C, Borzi C, et al. Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR. BMC Genom. 2015;16(1):1.
- Miotto E, Saccenti E, Lupini L, et al. Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen-and TaqMan-based chemistries. Cancer Epidemiol Biomarkers Prevent. 2014;23(12):2638–2642.
- Huggett JF, Cowen S, Foy CA. Considerations for digital PCR as an accurate molecular diagnostic tool. Clin Chem. 2015;61(1):79–88.
- Fu GK, Xu W, Wilhelmy J, et al. Molecular indexing enables quantitative targeted RNA sequencing and reveals poor efficiencies in standard library preparations. Proc Natl Acad Sci USA. 2014;111(5):1891–1896.
- Ståhlberg A, Kubista M. The workflow of single-cell expression profiling using quantitative real-time PCR. Expert Rev Mol Diagn. 2014;14(3):323–331.